Sanofi Reports 3Q18 Orthobiologic Revenue of €72MM, -24.2% vs. 3Q17
Sanofi Synvisc/Synvisc-One orthobiologics revenue continues to slide, accounting for €72MM (USD $88.7MM) 3Q18 revenue, -24.2% vs. 3Q17. Nov 01, 2018
NuVasive Reports 3Q18 Revenue of $271.3MM, +9.6% vs. 3Q17
NuVasive performance driven by increased case volume and new products, posts 3Q18 revenue of US $271.3MM, +9.6%vs. 3Q17. Nov 01, 2018
Orthofix Reports 3Q18 Revenue of $111.7MM, +6.1% vs. 3Q17
Orthofix performance driven by bone growth and trauma products with 3Q18 revenue of US $111.7MM, +6.1% vs. 3Q17. Oct 31, 2018
Zimmer Biomet Names Ivan Tornos New Group President, Orthopedics
Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1. Oct 31, 2018
Zimmer Biomet Reports 3Q18 Revenue of $1,637.4MM, +1.2% vs. 3Q17
Zimmer Biomet keeps pace with recovery efforts, posts 3Q18 orthopaedic revenue of US $1,637.4MM, +1.2% vs. 3Q17. Oct 30, 2018
Stryker Reports 3Q18 Revenue of $1.6BB, +4.2% vs. 3Q17
Momentum in knee reconstruction drove Stryker's 3Q18 orthopaedic performance, with revenue of US $1,689.7MM, +4.2% vs. 3Q17. Oct 30, 2018
Camber Spine Reaches $1MM Milestone with SPIRA-C
Camber Spine announced the milestone of USÂ $1MM with the SPIRA-C cervical interbody implant in less than six months. Oct 26, 2018
Anika Therapeutics Reports 3Q18 Revenue of $24.1MM, +0.4% vs. 3Q17
Anika Therapeutics posts 3Q18 orthobiologic revenue of $24.1MM, +0.4% vs. 3Q17. Oct 26, 2018
Life Spine Announces 3Q18 Growth, Sales +47% vs. 3Q17
Life Spine announced 3Q18 profit and revenue growth with sales up 47% vs. 3Q17. Oct 26, 2018
Vivex Biomedical Announces New CEO
Vivex Biomedical named Lisa Colleran to succeed Tracy Anderson as Chief Executive Officer. Mr. Anderson, founder of Vivex, will become Vice Chairman and remain on the Board of Directors. Oct 24, 2018
